No Data
No Data
Form 144 | AptarGroup(ATR.US) Officer Proposes to Sell 7.42 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 23, $AptarGroup(ATR.US)$ Officer ROBERT W KUHN intends to sell 49,463 shares of its common stock on Aug 23, with a total market value of approximately $7.42 million.
Investors in AptarGroup (NYSE:ATR) Have Seen Returns of 30% Over the Past Five Years
AptarGroup, Inc.'s (NYSE:ATR) Stock Has Fared Decently: Is the Market Following Strong Financials?
Aptargroup Insider Sold Shares Worth $1,054,974, According to a Recent SEC Filing
Express News | AptarGroup Says Unidose Is The Delivery System Approved With Neffy (Epinephrine Nasal Spray), The First And Only Needle-Free Treatment Approved By FDA For Emergency Treatment Of Patients With Allergic Reactions (Type I)
Aptar's Nasal Unidose System to Deliver Neffy (Epinephrine Nasal Spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
No Data